Critical Care

official impact factor 4.60
Search for
Advanced search
Critical Care
Tools
Open Access Highly Access

Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study

Saad Nseir*, Raphaël Favory, Elsa Jozefowicz, Franck Decamps, Florent Dewavrin, Guillaume Brunin, Christophe Di Pompeo, Daniel Mathieu, Alain Durocher and the VAT Study Group

Critical Care 2008, 12:R62 doi:10.1186/cc6890

Accesses  

  • Last 30 days: 66 accesses
  • Last year: 977 accesses
  • All time: 6717 accesses

Cited by

BioMed Central: 2 citations

Research   Open Access Highly Accessed

Remifentanil discontinuation and subsequent intensive care unit-acquired infection: a cohort study

Saad Nseir, Jérémy Hoel, Guillaume Grailles, Aude Soury-Lavergne, Christophe Di Pompeo, Daniel Mathieu, Alain Durocher Critical Care 2009, 13:R60 (21 April 2009)

Abstract | Full text | PDF | PubMed | Editor’s summary

Remifentanil discontinuation is associated with an increased risk of ICU-acquired infection, an observation that reiterates previous reports on the negative effects of opioid withdrawal on the immune system.

Commentary   Free

Ventilator-associated tracheobronchitis (VAT): questions, answers, and a new paradigm?

Donald E Craven Critical Care 2008, 12:157 (18 June 2008)

Abstract | Full text | PDF | PubMed

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations